Some patients were screened for antiphospholipid (aPL) antibodies, including Lupus anticoagulant (LA), anti‐cardiolipin (aCL) antibodies, and anti‐beta2 glycoprotein I (aβ2GPI) antibodies. This evidence concerns the gene FASLG and systemic lupus erythematosus.